Active case finding of tuberculosis in Europe

A Tuberculosis Network European Trials Group (TBNET) survey

G. H. Bothamley, L. Ditiu, G. B. Migliori, C. Lange, H. Hafizi, N. Mezhlumyan, S. Mamedova, M. Wanlin, H. Zutic, D. Stefanova, A. Simunovic, C. Hadjianastassiou, D. Falzon, A. Salakaia, S. Georgia, T. Blöndal, D. Chemtob, B. K. Khasanovna, A. Elmira, J. Leimans & 39 others E. Davidaviciene, A. Vidoevska, A. P. Asciak, O. Bojovic, B. A. Winje, M. Korzeniewska, I. Solovic, D. Erzen, S. Saidaliev, D. M. Khaldurdyevna, O. Sakalska, U. D. Djumabaevna, B. Schmidgruber, O. M. Kalechitz, G. Vankersshaever, S. Kos, P. Ravn, K. Kliiman, R. Ruohonen, H. P. Mallet, O. Bock-Hensley, G. Loytzved, A. Somoskövi, I. Horvath, J. Keane, L. R. Codecasa, F. Chaussade, V. Soltan, S. Arend, M. Villar, I. Husar, P. Stoicescu, L. Rybka, D. Pesut, J. M. Garcia, J. Bruchfeld, I. Julander, J. P. Janssens, O. Ergonul

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Tuberculosis control depends on successful case finding and treatment of individuals infected with Mycobacterium tuberculosis. Passive case finding is widely practised: the present study aims to ascertain the consensus and possible improvements in active case finding across Europe. Recommendations from national guidelines were collected from 50 countries of the World Health Organization European region using a standard questionnaire. Contacts are universally screened for active tuberculosis and latent tuberculosis infection (LTBI). Most countries (>70%) screen those with HIV infection, prisoners and in-patient contacts. Screening of immigrants is related to their contribution to national rates of tuberculosis. Only 25 (50%) out of 50 advise a request for symptoms in their guidelines. A total of 36 (72%) out of 50 countries recommend sputum examination for those with a persistent cough; 13 countries do not, even if the chest radiograph suggests tuberculosis. Nearly all countries (49 out of 50) use tuberculin skin testing (TST); 27 (54%) out of 50 countries also perform chest radiography irrespective of the TST result. Interpretation of the TST varies widely. All countries use 6-9 months of isoniazid for treatment of LTBI, with an estimated median (range) uptake of 55% (5-92.5%). Symptoms and sputum examination could be used more widely when screening for active tuberculosis. Treatment of latent tuberculosis infection might be better focused by targeted use of interferon-c release assays. Copyright

Original languageEnglish
Pages (from-to)1023-1030
Number of pages8
JournalEuropean Respiratory Journal
Volume32
Issue number4
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Tuberculosis
Latent Tuberculosis
Tuberculin
Sputum
Skin
Thorax
Guidelines
Prisoners
Isoniazid
Mycobacterium tuberculosis
Cough
Radiography
Interferons
HIV Infections
Therapeutics
Surveys and Questionnaires

Keywords

  • Active case finding
  • Contacts
  • Europe
  • Screening
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Active case finding of tuberculosis in Europe : A Tuberculosis Network European Trials Group (TBNET) survey. / Bothamley, G. H.; Ditiu, L.; Migliori, G. B.; Lange, C.; Hafizi, H.; Mezhlumyan, N.; Mamedova, S.; Wanlin, M.; Zutic, H.; Stefanova, D.; Simunovic, A.; Hadjianastassiou, C.; Falzon, D.; Salakaia, A.; Georgia, S.; Blöndal, T.; Chemtob, D.; Khasanovna, B. K.; Elmira, A.; Leimans, J.; Davidaviciene, E.; Vidoevska, A.; Asciak, A. P.; Bojovic, O.; Winje, B. A.; Korzeniewska, M.; Solovic, I.; Erzen, D.; Saidaliev, S.; Khaldurdyevna, D. M.; Sakalska, O.; Djumabaevna, U. D.; Schmidgruber, B.; Kalechitz, O. M.; Vankersshaever, G.; Kos, S.; Ravn, P.; Kliiman, K.; Ruohonen, R.; Mallet, H. P.; Bock-Hensley, O.; Loytzved, G.; Somoskövi, A.; Horvath, I.; Keane, J.; Codecasa, L. R.; Chaussade, F.; Soltan, V.; Arend, S.; Villar, M.; Husar, I.; Stoicescu, P.; Rybka, L.; Pesut, D.; Garcia, J. M.; Bruchfeld, J.; Julander, I.; Janssens, J. P.; Ergonul, O.

In: European Respiratory Journal, Vol. 32, No. 4, 10.2008, p. 1023-1030.

Research output: Contribution to journalArticle

Bothamley, GH, Ditiu, L, Migliori, GB, Lange, C, Hafizi, H, Mezhlumyan, N, Mamedova, S, Wanlin, M, Zutic, H, Stefanova, D, Simunovic, A, Hadjianastassiou, C, Falzon, D, Salakaia, A, Georgia, S, Blöndal, T, Chemtob, D, Khasanovna, BK, Elmira, A, Leimans, J, Davidaviciene, E, Vidoevska, A, Asciak, AP, Bojovic, O, Winje, BA, Korzeniewska, M, Solovic, I, Erzen, D, Saidaliev, S, Khaldurdyevna, DM, Sakalska, O, Djumabaevna, UD, Schmidgruber, B, Kalechitz, OM, Vankersshaever, G, Kos, S, Ravn, P, Kliiman, K, Ruohonen, R, Mallet, HP, Bock-Hensley, O, Loytzved, G, Somoskövi, A, Horvath, I, Keane, J, Codecasa, LR, Chaussade, F, Soltan, V, Arend, S, Villar, M, Husar, I, Stoicescu, P, Rybka, L, Pesut, D, Garcia, JM, Bruchfeld, J, Julander, I, Janssens, JP & Ergonul, O 2008, 'Active case finding of tuberculosis in Europe: A Tuberculosis Network European Trials Group (TBNET) survey', European Respiratory Journal, vol. 32, no. 4, pp. 1023-1030. https://doi.org/10.1183/09031936.00011708
Bothamley, G. H. ; Ditiu, L. ; Migliori, G. B. ; Lange, C. ; Hafizi, H. ; Mezhlumyan, N. ; Mamedova, S. ; Wanlin, M. ; Zutic, H. ; Stefanova, D. ; Simunovic, A. ; Hadjianastassiou, C. ; Falzon, D. ; Salakaia, A. ; Georgia, S. ; Blöndal, T. ; Chemtob, D. ; Khasanovna, B. K. ; Elmira, A. ; Leimans, J. ; Davidaviciene, E. ; Vidoevska, A. ; Asciak, A. P. ; Bojovic, O. ; Winje, B. A. ; Korzeniewska, M. ; Solovic, I. ; Erzen, D. ; Saidaliev, S. ; Khaldurdyevna, D. M. ; Sakalska, O. ; Djumabaevna, U. D. ; Schmidgruber, B. ; Kalechitz, O. M. ; Vankersshaever, G. ; Kos, S. ; Ravn, P. ; Kliiman, K. ; Ruohonen, R. ; Mallet, H. P. ; Bock-Hensley, O. ; Loytzved, G. ; Somoskövi, A. ; Horvath, I. ; Keane, J. ; Codecasa, L. R. ; Chaussade, F. ; Soltan, V. ; Arend, S. ; Villar, M. ; Husar, I. ; Stoicescu, P. ; Rybka, L. ; Pesut, D. ; Garcia, J. M. ; Bruchfeld, J. ; Julander, I. ; Janssens, J. P. ; Ergonul, O. / Active case finding of tuberculosis in Europe : A Tuberculosis Network European Trials Group (TBNET) survey. In: European Respiratory Journal. 2008 ; Vol. 32, No. 4. pp. 1023-1030.
@article{258126c74895478ca490373467b4b8e3,
title = "Active case finding of tuberculosis in Europe: A Tuberculosis Network European Trials Group (TBNET) survey",
abstract = "Tuberculosis control depends on successful case finding and treatment of individuals infected with Mycobacterium tuberculosis. Passive case finding is widely practised: the present study aims to ascertain the consensus and possible improvements in active case finding across Europe. Recommendations from national guidelines were collected from 50 countries of the World Health Organization European region using a standard questionnaire. Contacts are universally screened for active tuberculosis and latent tuberculosis infection (LTBI). Most countries (>70{\%}) screen those with HIV infection, prisoners and in-patient contacts. Screening of immigrants is related to their contribution to national rates of tuberculosis. Only 25 (50{\%}) out of 50 advise a request for symptoms in their guidelines. A total of 36 (72{\%}) out of 50 countries recommend sputum examination for those with a persistent cough; 13 countries do not, even if the chest radiograph suggests tuberculosis. Nearly all countries (49 out of 50) use tuberculin skin testing (TST); 27 (54{\%}) out of 50 countries also perform chest radiography irrespective of the TST result. Interpretation of the TST varies widely. All countries use 6-9 months of isoniazid for treatment of LTBI, with an estimated median (range) uptake of 55{\%} (5-92.5{\%}). Symptoms and sputum examination could be used more widely when screening for active tuberculosis. Treatment of latent tuberculosis infection might be better focused by targeted use of interferon-c release assays. Copyright",
keywords = "Active case finding, Contacts, Europe, Screening, Tuberculosis",
author = "Bothamley, {G. H.} and L. Ditiu and Migliori, {G. B.} and C. Lange and H. Hafizi and N. Mezhlumyan and S. Mamedova and M. Wanlin and H. Zutic and D. Stefanova and A. Simunovic and C. Hadjianastassiou and D. Falzon and A. Salakaia and S. Georgia and T. Bl{\"o}ndal and D. Chemtob and Khasanovna, {B. K.} and A. Elmira and J. Leimans and E. Davidaviciene and A. Vidoevska and Asciak, {A. P.} and O. Bojovic and Winje, {B. A.} and M. Korzeniewska and I. Solovic and D. Erzen and S. Saidaliev and Khaldurdyevna, {D. M.} and O. Sakalska and Djumabaevna, {U. D.} and B. Schmidgruber and Kalechitz, {O. M.} and G. Vankersshaever and S. Kos and P. Ravn and K. Kliiman and R. Ruohonen and Mallet, {H. P.} and O. Bock-Hensley and G. Loytzved and A. Somosk{\"o}vi and I. Horvath and J. Keane and Codecasa, {L. R.} and F. Chaussade and V. Soltan and S. Arend and M. Villar and I. Husar and P. Stoicescu and L. Rybka and D. Pesut and Garcia, {J. M.} and J. Bruchfeld and I. Julander and Janssens, {J. P.} and O. Ergonul",
year = "2008",
month = "10",
doi = "10.1183/09031936.00011708",
language = "English",
volume = "32",
pages = "1023--1030",
journal = "European Journal of Respiratory Diseases",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "4",

}

TY - JOUR

T1 - Active case finding of tuberculosis in Europe

T2 - A Tuberculosis Network European Trials Group (TBNET) survey

AU - Bothamley, G. H.

AU - Ditiu, L.

AU - Migliori, G. B.

AU - Lange, C.

AU - Hafizi, H.

AU - Mezhlumyan, N.

AU - Mamedova, S.

AU - Wanlin, M.

AU - Zutic, H.

AU - Stefanova, D.

AU - Simunovic, A.

AU - Hadjianastassiou, C.

AU - Falzon, D.

AU - Salakaia, A.

AU - Georgia, S.

AU - Blöndal, T.

AU - Chemtob, D.

AU - Khasanovna, B. K.

AU - Elmira, A.

AU - Leimans, J.

AU - Davidaviciene, E.

AU - Vidoevska, A.

AU - Asciak, A. P.

AU - Bojovic, O.

AU - Winje, B. A.

AU - Korzeniewska, M.

AU - Solovic, I.

AU - Erzen, D.

AU - Saidaliev, S.

AU - Khaldurdyevna, D. M.

AU - Sakalska, O.

AU - Djumabaevna, U. D.

AU - Schmidgruber, B.

AU - Kalechitz, O. M.

AU - Vankersshaever, G.

AU - Kos, S.

AU - Ravn, P.

AU - Kliiman, K.

AU - Ruohonen, R.

AU - Mallet, H. P.

AU - Bock-Hensley, O.

AU - Loytzved, G.

AU - Somoskövi, A.

AU - Horvath, I.

AU - Keane, J.

AU - Codecasa, L. R.

AU - Chaussade, F.

AU - Soltan, V.

AU - Arend, S.

AU - Villar, M.

AU - Husar, I.

AU - Stoicescu, P.

AU - Rybka, L.

AU - Pesut, D.

AU - Garcia, J. M.

AU - Bruchfeld, J.

AU - Julander, I.

AU - Janssens, J. P.

AU - Ergonul, O.

PY - 2008/10

Y1 - 2008/10

N2 - Tuberculosis control depends on successful case finding and treatment of individuals infected with Mycobacterium tuberculosis. Passive case finding is widely practised: the present study aims to ascertain the consensus and possible improvements in active case finding across Europe. Recommendations from national guidelines were collected from 50 countries of the World Health Organization European region using a standard questionnaire. Contacts are universally screened for active tuberculosis and latent tuberculosis infection (LTBI). Most countries (>70%) screen those with HIV infection, prisoners and in-patient contacts. Screening of immigrants is related to their contribution to national rates of tuberculosis. Only 25 (50%) out of 50 advise a request for symptoms in their guidelines. A total of 36 (72%) out of 50 countries recommend sputum examination for those with a persistent cough; 13 countries do not, even if the chest radiograph suggests tuberculosis. Nearly all countries (49 out of 50) use tuberculin skin testing (TST); 27 (54%) out of 50 countries also perform chest radiography irrespective of the TST result. Interpretation of the TST varies widely. All countries use 6-9 months of isoniazid for treatment of LTBI, with an estimated median (range) uptake of 55% (5-92.5%). Symptoms and sputum examination could be used more widely when screening for active tuberculosis. Treatment of latent tuberculosis infection might be better focused by targeted use of interferon-c release assays. Copyright

AB - Tuberculosis control depends on successful case finding and treatment of individuals infected with Mycobacterium tuberculosis. Passive case finding is widely practised: the present study aims to ascertain the consensus and possible improvements in active case finding across Europe. Recommendations from national guidelines were collected from 50 countries of the World Health Organization European region using a standard questionnaire. Contacts are universally screened for active tuberculosis and latent tuberculosis infection (LTBI). Most countries (>70%) screen those with HIV infection, prisoners and in-patient contacts. Screening of immigrants is related to their contribution to national rates of tuberculosis. Only 25 (50%) out of 50 advise a request for symptoms in their guidelines. A total of 36 (72%) out of 50 countries recommend sputum examination for those with a persistent cough; 13 countries do not, even if the chest radiograph suggests tuberculosis. Nearly all countries (49 out of 50) use tuberculin skin testing (TST); 27 (54%) out of 50 countries also perform chest radiography irrespective of the TST result. Interpretation of the TST varies widely. All countries use 6-9 months of isoniazid for treatment of LTBI, with an estimated median (range) uptake of 55% (5-92.5%). Symptoms and sputum examination could be used more widely when screening for active tuberculosis. Treatment of latent tuberculosis infection might be better focused by targeted use of interferon-c release assays. Copyright

KW - Active case finding

KW - Contacts

KW - Europe

KW - Screening

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=58149251629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149251629&partnerID=8YFLogxK

U2 - 10.1183/09031936.00011708

DO - 10.1183/09031936.00011708

M3 - Article

VL - 32

SP - 1023

EP - 1030

JO - European Journal of Respiratory Diseases

JF - European Journal of Respiratory Diseases

SN - 0903-1936

IS - 4

ER -